Monocytic and lymphocytic inflammatory reaction during myocardial infarction complicated with acute heart failure in patients with type 2 diabetes mellitus
Open Access
- 18 November 2021
- journal article
- research article
- Published by Arterialnaya Gipertenziya in Translational Medicine
- Vol. 8 (4) , 6-17
Abstract
Background. The processes of inflammation and repair in the area of myocardial infarction (MI) are carried out and regulated by various populations of immune cells, including monocytes, lymphocytes, and NK-cells. The success of myocardial recovery after infarction and the risk of developing acute heart failure (AHF) depend on their adequate interaction. The presence of type 2 diabetes mellitus (T2DM), in which chronic low-gradient inflammation occurs, can affect the monocytic and lymphocytic response in MI, which may contribute to the development of AHF.Objective. to assess the features of monocytic and lymphocytic responses in patients with MI T2DM complicated by the development of AHF.Design and methods. The study included 121 patients with MI T2DM (38 of them with AHF). The control group included 59 patients without diabetes mellitus (including 13 patients with AHF). For all patients within 1 day, on days 3, 5 and 12 of MI, the total number of monocytes and lymphocytes, the monocytes-to-lymphocytes ratio (MLR), subpopulations of monocytes and T-lymphocytes with NK cells (T&NK-cells) were determined by flow cytometry.Results. In patients with T2DM, the number of monocytes of different subpopulations did not differ depending on the development of AHF. In patients without T2DM with MI, complicated by AHF, compared with patients without AHF, on day 3, the number of CD14(+)CD16(-)monocytes was higher: 1018 (824; 1144) vs 593 (557; 677) cells/μL, p Conclusion. In patients with T2DM, the development of AHF is associated with a low number of lymphocytes in the absence of a pronounced monocytic response. In non-diabetic patients, the development of AHF is associated with an increase in CD16(-)monocytes and a lower number of CD16 (+) T&NК-cells.Keywords
This publication has 21 references indexed in Scilit:
- Potential role of invariant natural killer T cells in outcomes of acute myocardial infarctionInternational Journal of Cardiology, 2015
- Intermediate Monocytes Lead to Enhanced Myocardial Remodelling in STEMI Patients With DiabetesInternational Heart Journal, 2015
- Interplay of NK cells and monocytes in vascular inflammation and myocardial infarctionFrontiers in Physiology, 2014
- Senescent CD14+CD16+ Monocytes Exhibit Proinflammatory and Proatherosclerotic ActivityThe Journal of Immunology, 2011
- Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial InfarctionCirculation, 2010
- Impact of Heterogeneity of Human Peripheral Blood Monocyte Subsets on Myocardial Salvage in Patients With Primary Acute Myocardial InfarctionJACC, 2009
- CD14++CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patientsKidney International, 2008
- The CD14+ CD16+ blood monocytes: their role in infection and inflammationJournal of Leukocyte Biology, 2006
- CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levelsThrombosis and Haemostasis, 2004
- Crystal Structure of the Extracellular Domain of a Human FcγRIIIImmunity, 2000